HERBS GROUP (02593) announced its interim results, reporting a net loss of HKD 3.71 million, narrowing 50.8% year-on-year.
Caoji Group (02593) announced its performance for the six months ending June 30, 2026, with revenue of HKD 110 million, a year-on-year decrease of 6.2%; and a net loss of HKD 3.71 million, a year-on-year narrowing of 50.8%. This change is mainly due to a reduction in advertising and promotional expenses during the reporting period (including but not limited to online advertising, offline advertising, and commissions for artists and KOLs), partially offset by the decline in group revenue and gross profit during the reporting period. The decrease in revenue and gross profit is primarily attributed to a reduction in sales from retail operations during the reporting period.
HERBS GROUP (02593) announced its performance for the six months ended June 30, 2026, with revenue of HK$110 million, a year-on-year decrease of 6.2%; net loss of HK$3.71 million, a year-on-year reduction of 50.8%. This change was mainly attributed to a reduction in advertising and promotional expenses during the reporting period (including but not limited to online advertising, offline advertising, and the hiring of artists and KOLs), which was partially offset by a decline in the group's revenue and gross profit in the reporting period. The decrease in revenue and gross profit was primarily due to a reduction in retail sales during the reporting period.
During the reporting period, in response to the challenging market environment, the group actively developed new brands and products to expand its product portfolio, including new products Herb Princess Ergot Liuyin + PQQ, Herb Princess Menopause Beauty, and MedHerbs Medical Grade Sweet Sleep Relaxation Formula. Looking ahead, the group plans to continue innovation in the second half of 2026 by developing more new products and upgrading existing ones, aiming to further narrow the losses for 2026 compared to 2025.
Related Articles
GEMINI INV (00174): Shen Peiying will be reassigned as a non-executive director.
SHUANGHUA H (01241) issues profit warning, expecting a mid-term post-tax net loss of approximately 15.2 million yuan.
NEWBORNTOWN (09911) achieved a profit attributable to equity shareholders of $101 million in the first half of the year, an increase of 18.7% year-on-year.
GEMINI INV (00174): Shen Peiying will be reassigned as a non-executive director.
SHUANGHUA H (01241) issues profit warning, expecting a mid-term post-tax net loss of approximately 15.2 million yuan.
NEWBORNTOWN (09911) achieved a profit attributable to equity shareholders of $101 million in the first half of the year, an increase of 18.7% year-on-year.
RECOMMEND
